ClouDr Group Ltd

FRA:H3L (China)  
€ 0.38 (0%) May 15
At Loss
P/B:
1.00
Market Cap:
€ 236.97M ($ 257.50M)
Enterprise V:
€ 195.03M ($ 211.94M)
Volume:
-
Avg Vol (2M):
49.00
Warning! GuruFocus detected 4 Severe warning signs with H3L. Try a 7-Day Free Trial to check it out.
Also Trade In:
Volume:
-
Market Cap €:
236.97M
Market Cap $:
257.50M
At Loss
Avg Vol (2M):
49.00
Enterprise Value €:
195.03M
Enterprise Value $:
211.94M
PB Ratio:
1.00
Alerts Website Sources Stock PDF
Dataset
Financial Download P  Manual of Stocks™

Business Description

ClouDr Group Ltd

ISIN : KYG2216H1011
https://www.cloudr.cn
No. 998 Wenyi West Road (Haichuang Yuan), Wuchang Street, Rooms 501, 5th Floor, Building 12, Yuhang District, Zhejiang Province, Hangzhou, CHN
Compare
Compare
HKSE:01931HKSE:02192HKSE:00314HKSE:02289HKSE:00673HKSE:06833HKSE:00718HKSE:08372HKSE:00401MCKCORCAHHSICSHSE:601607HKSE:01099MIL:AMPNZSE:EBOXSWX:GALETSE:7459TSE:2784
Traded in other countries / regions
09955.Hong KongH3L.Germany
IPO Date
2022-12-02
Description
ClouDr Group Ltd provides supplies and SaaS to hospitals and pharmacies, digital marketing services to pharmaceutical companies, and online consultation and prescriptions to patients, all centered around chronic condition management. Its segments include in-hospital solutions, pharmacy solutions, and individual chronic condition management solutions. The company's in-hospital solution consists of sales of medical devices, consumables and pharmaceuticals, hospital SaaS, and digital marketing services to pharmaceutical companies. It generates revenues from sales of hospital and pharmacy supplies and individual chronic condition management products.

Financial Strength

6/10
Name Current Vs Industry Vs History
Cash-To-Debt 2.23
Equity-to-Asset 0.62
Debt-to-Equity 0.15
Debt-to-EBITDA -0.84
Piotroski F-Score 3/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score -2.39
Distress
Grey
Safe
Beneish M-Score -2.65
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year Revenue Growth Rate 62.1
3-Year EBITDA Growth Rate 58.7
3-Year EPS without NRI Growth Rate 52.1
3-Year FCF Growth Rate 18.9
Future 3-5Y Total Revenue Growth Rate 21.85

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 53.59
9-Day RSI 57.87
14-Day RSI 55.44
6-1 Month Momentum % -62.29
12-1 Month Momentum % -72.59

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 2.09
Quick Ratio 1.82
Cash Ratio 0.54
Days Inventory 32.53
Days Sales Outstanding 77.58
Days Payable 16.26

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -1.1
Shareholder Yield % -6.78

Profitability Rank

1/10
Name Current Vs Industry Vs History
Gross Margin % 24.64
Operating Margin % -8.61
Net Margin % -8.75
FCF Margin % -7.14
ROE % -17.64
ROA % -11.21
ROIC % -19.34
ROC (Joel Greenblatt) % -33.49
ROCE % -16.62

GF Value Rank

Name Current Vs Industry Vs History
PS Ratio 0.46
PB Ratio 1
Price-to-Tangible-Book 1.24
EV-to-EBIT -4.75
EV-to-EBITDA -4.75
EV-to-Revenue 0.41
EV-to-Forward-Revenue 0.81
EV-to-FCF -5.72
Price-to-Net-Current-Asset-Value 1.54
Earnings Yield (Greenblatt) % -21.05
FCF Yield % -14.43

Financials

FRA:H3L's 30-Y Financials
AAPL
Income Statement Breakdown FY
No Enough Data
AAPL
Balance Sheet Breakdown
No Enough Data
AAPL
Cashflow Statement Breakdown
No Enough Data

Historical Operating Revenue by Business Segment

Historical Operating Revenue by Geographic Region

5-Step DuPont Analysis as of
No Enough Data

Guru Trades

See Details
To

Insider Trades

See Details
To

Peter Lynch Chart

Y-axis scale:
Interactive Chart
To

Performance

Dividend
Log
Bar
To

Annualized Return %  

Symbol
1 Week
1 Month
3 Months
6 Months
YTD
1 Year
3 Years
5 Years
10 Years

Total Annual Return %  

Symbol
2024
2023
2022
2021
2020
2019
2018
2017
2016
2015

ClouDr Group Ltd Executives

Details

GF Value

FRA:H3L

Valuation Chart

Year:

Analyst Estimate

Key Statistics

Name Value
Revenue (TTM) (Mil €) 474.792
EPS (TTM) (€) -0.077
Beta 0
Volatility % 59.39
14-Day RSI 55.44
14-Day ATR (€) 0.019083
20-Day SMA (€) 0.346
12-1 Month Momentum % -72.59
52-Week Range (€) 0.266 - 1.05
Shares Outstanding (Mil) 587.04

Piotroski F-Score Details

Year:
Component Result
Piotroski F-Score 3
Positive ROA
Positive CFROA
Higher ROA yoy
CFROA > ROA
Lower Leverage yoy
Higher Current Ratio yoy
Less Shares Outstanding yoy
Higher Gross Margin yoy
Higher Asset Turnover yoy

ClouDr Group Ltd Filings

Filing Date Document Date Form
No Filing Data

ClouDr Group Ltd Stock Events

Financials Calendars
Event Date Price(€)
No Event Data

ClouDr Group Ltd Frequently Asked Questions

What is ClouDr Group Ltd(FRA:H3L)'s stock price today?
The current price of FRA:H3L is €0.38. The 52 week high of FRA:H3L is €1.05 and 52 week low is €0.27.
When is next earnings date of ClouDr Group Ltd(FRA:H3L)?
The next earnings date of ClouDr Group Ltd(FRA:H3L) is .
Does ClouDr Group Ltd(FRA:H3L) pay dividends? If so, how much?
ClouDr Group Ltd(FRA:H3L) does not pay dividend.

Press Release

Subject Date
No Press Release
Research Tools
All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board
Product
Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文
Education
Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation
Company
About GuruFocus Career Contact Us ETF Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program
Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey
Follow Us
download GuruFocus on Apple store download GuruFocus on Google Play
Disclaimers
GuruFocus.com is not operated by a broker or a dealer. It has an affiliated registered investment adviser, which serves as the subadviser to an exchange traded fund. This investment adviser does not provide advice to individual investors. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.
© 2004-2024 GuruFocus.com, LLC. All Rights Reserved.